Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 The Company is scheduling Earning Conference Call on Wednesday, 9th November, 2022 at 12:30 PM. Details of meeting attached below. Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com
07-11-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Corrigendum To Intimation Letter Of Board Meeting Dated 28Th October, 2022.

 In continuation to our letter dated 28th October, 2022, about the intimation of Board Meeting to be held on, 7th November, 2022. There was a typographical error where by Monday was inadvertently typed as Wednesday. This has to be read as Monday, 7th November, 2022 instead of Wednesday.
31-10-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for For Un-Audited Results For The Quarter Ended 30.09.2022.

 THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 ,inter alia, to consider and approve With respect to the captioned subject, please be informed that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Wednesday, 7th November, 2022 inter alia, to consider the Un-audited Standalone and Consolidated Financial Results for the quarter and half year ended on 30thSeptember, 2022. Further, in continuation of our Letter dated 27th September 2022, the Trading Window in respect of dealing in the Company's Securities was closed for all Directors/Designated Employees from the opening of the trading hours on Saturday, 1stOctober, 2022, which shall remain closed till the closure of trading hours on 9th November, 2022 (both days inclusive) i.e. till the completion of 48 hours after the declaration of financial results as per the policy for prohibition of Insider Trading ("the Code") adopted by the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time.
28-10-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Credit Rating

 We hereby inform you that Credit Rating assigned and upgraded to the Company by the Credit Rating Agency i.e Acuite Ratings & Research Limited as under: Product Quantum (Rs. Cr) Long Term Rating Short Term Rating Bank Loan Ratings 10.00 - ACUITE A3+ / Assigned Bank Loan Ratings 25.85 ACUITE BBB / Stable / Upgraded - Bank Loan Ratings 30.00 ACUITE BBB / Stable / Assigned - Bank Loan Ratings 63.25 - ACUITE A3+ / Upgraded Tot al Out standing Quant um (Rs. Cr) 129.10 - - Tot al Withdrawn Quantum (Rs. Cr) 0.00 - - This is for your information and record.
27-10-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Statement Of Investor Complaints For The Quarter Ended September 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer
18-10-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the half year ended September 30, 2022 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record.
07-10-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 In terms of Regulation 30 of the SEBI (LODR) Regulations, 2015, we are enclosing herewith a copy of the press release titled - THEMIS MEDICARE PARTNERS WITH NFL BIOSCIENCES FOR THE DEVELOPMENT OF NFL-101 IN INDIA.
06-10-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company had an online meeting with Analysts/Investors on Thursday, 29th September 2022; the details of the same are given below: Sr. no. Name Venue 1 Pi Square Investments Zoom Call Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.
30-09-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company will meet with Analysts/Investors on Thursday, 29th September 2022; the details of the same are given below: Sr. no. Name Venue 1 Pi Square Investments Zoom Call Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com
28-09-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

 We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Securities of the Company shall remain closed from Saturday 1stOctober, 2022 and will re-open after completion of 48 hours from the declaration of financial results for the quarter ended 30thSeptember, 2022 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the quarter ended 30thSeptember, 2022 shall be intimated in due course.
27-09-2022
Next Page
Close

Let's Open Free Demat Account